首页> 外文期刊>Journal of the Chinese Chemical Society >Spectrophotometric and atomic absorption spectroscopic determination of some fluoroquinolone antibacterials by ion-pair complex formation with bismuth (III) tetraiodide
【24h】

Spectrophotometric and atomic absorption spectroscopic determination of some fluoroquinolone antibacterials by ion-pair complex formation with bismuth (III) tetraiodide

机译:分光光度法和原子吸收光谱法测定四碘化铋(III)离子对络合物形成的某些氟喹诺酮类抗菌剂

获取原文
获取原文并翻译 | 示例
           

摘要

New simple spectrophotometric and atomic absorption spectrometric (AAS) methods have been developed for the determination of levofloxacin (I), norfloxacin (II), and ciprofloxacin (III) in pure form, tablet formulations, and spiked human urine. The methods are based on the formation of ion-pair associates between the drugs and the inorganic complex, bismuth (III) tetraiodide. The reaction occurs in acidic medium to form orange-red ion-pair associates which are instantaneously precipitated. The formed precipitates are then filtered off and the residual unreacted metal complex in the filtrate is determined either spectrophotometrically at 453 nm or by AAS at 223.1 nm. Also, the precipitates may be dissolved in acetone and quantified spectrophotometrically at 469 nm or decomposed by hydrochloric acid, and the bismuth content is determined by AAS at 223.1 nm. The methods permit the determination of the three studied drugs in the range of 5-80 mu g mL(-1). The proposed methods were successfully applied to determine these drugs in their tablet formulations and spiked urine samples without any evidence for interference from pharmaceutical additives or biological matrix. The results were in good agreement with those obtained by the reference methods. The proposed methods, especially if automated, can be confidently applied for quality control and routine analysis of the studied drugs.
机译:已开发出新的简单分光光度法和原子吸收光谱法(AAS),用于测定纯形式,片剂和残留的人体尿液中的左氧氟沙星(I),诺氟沙星(II)和环丙沙星(III)。该方法基于药物与无机配合物四碘化铋(III)之间离子对缔合体的形成。该反应在酸性介质中发生,形成橙红色离子对缔合体,这些缔合体立即沉淀出来。然后将形成的沉淀物滤出,并通过分光光度法在453 nm下或通过AAS在223.1 nm下测定滤液中残留的未反应金属络合物。同样,可以将沉淀物溶解在丙酮中,并在469 nm处用分光光度法定量或用盐酸分解,并通过AAS在223.1 nm下测定铋含量。该方法可以确定三种研究药物的范围为5-80μg mL(-1)。所提出的方法已成功应用于片剂制剂和尿液加标样品中这些药物的测定,而没有任何证据表明药物添加剂或生物基质的干扰。结果与参考方法获得的结果吻合良好。所提出的方法,尤其是自动方法,可以放心地应用于所研究药物的质量控制和常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号